Jul. 15 at 10:53 AM
The U.S. life sciences tools maker
$WAT shares fell -13.81% on Monday at
$304.18, after announcing plans to merge with Becton Dickinson’s Biosciences & Diagnostic Solutions unit. Waters will take on
$4 billion in debt & issue + 39.2% of its stock to Becton Dickinson shareholders, under the terms of the deal. Becton shareholders will also receive a
$4B payout.
$BDX shares added +0.64% at
$177.09. Waters stock is down -10.82% in the past month, -18.01% in 2025 & -3.96% y/y, with a market cap of
$18.1B.